Credit Agricole Upgrades Bristol-Myers Squibb (BMY) Two Notches to Outperform
Get Alerts BMY Hot Sheet
Price: $67.33 +2.84%
Rating Summary:
12 Buy, 22 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
12 Buy, 22 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Credit Agricole upgraded Bristol-Myers Squibb (NYSE: BMY) from Underperform to Outperform, price target raised from $35 to $38.
For an analyst ratings summary and ratings history on Bristol-Myers Squibb click here. For more ratings news on Bristol-Myers Squibb click here.
Shares of Bristol-Myers Squibb closed at $34.16 yesterday.
For an analyst ratings summary and ratings history on Bristol-Myers Squibb click here. For more ratings news on Bristol-Myers Squibb click here.
Shares of Bristol-Myers Squibb closed at $34.16 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Reiterates Buy Rating on Bristol-Myers Squibb Co. (BMY)
- Jefferies Upgrades Fortescue Metals Group Ltd. (FMG:AU) (FSUGY) to Hold
- Baird Upgrades Parsons Corp. (PSN) to Outperform
Create E-mail Alert Related Categories
UpgradesRelated Entities
Credit AgricoleSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share